首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1477211

免疫療法藥物市場，依治療類型、依給藥途徑、依適應症、依配銷通路、依地理位置

Immunotherapy Drugs Market, By Therapy Type, By Route of Administration, By Indication, By Distribution Channel, By Geography

出版日期: 2024年04月11日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2024年全球免疫療法藥物市場價值為1,665.5億美元，預計到2031年將達到3,517.3億美元，2024年至2031年年複合成長率（CAGR）為11.3%。

報告範圍		報告詳情
基準年：	2023年	2024 年市場規模：	1665.5 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測 2024 年至 2031 年複合年成長率：	11.30%	2031 年價值預測：	3517.3 億美元

數字。全球免疫治療藥物市場佔有率（%），依地區，2024年

免疫療法藥物利用人體的免疫系統來對抗癌症和其他疾病。這些藥物透過增強現有的免疫細胞或將新的免疫細胞引入體內來刺激免疫系統。免疫療法的主要類型包括單株抗體、癌症疫苗、檢查點抑制劑和過繼性細胞轉移療法。免疫療法藥物正日益成為各種癌症類型的治療標準，因為與化療相比，這些藥物已被證明可以提供持久的緩解率和更輕微的副作用。過去幾年，在新藥核准和不同疾病適應症的採用不斷增加的推動下，市場出現了顯著成長。

市場動態：

全球免疫療法藥物市場的成長是由全球癌症和其他慢性病盛行率上升所推動的。由於開發新型免疫療法的研發資金增加、FDA 對免疫療法的一致批准以及相對於其他可用治療方案的優越性等因素，該市場獲得了動力。然而，這些藥物的高成本以及某些地區的報銷問題是該市場的主要限制因素。市場參與者也正在投資管道產品，以將當前的治療領域擴展到新的適應症。

研究的主要特點：

該報告對全球免疫療法藥物市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模（十億美元）和年複合成長率（CAGR%）。
它闡明了不同區隔市場的潛在收入機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
它根據以下參數描述了全球免疫療法藥物市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
全球免疫療法藥物市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
利害關係人可以透過用於分析全球免疫療法藥物市場的各種策略矩陣輕鬆做出決策。

概述
免疫檢查點抑制劑
單株抗體
裸單株抗體
綴合單株抗體
雙特異性單株抗體
疫苗
預防疫苗
治療性疫苗
過繼性細胞療法
腫瘤浸潤淋巴細胞（TIL）療法
CAR T細胞療法
工程 T 細胞受體 (TCR) 療法
自然殺手（NK）細胞療法
免疫系統調節劑
干擾素
免疫調節劑 (IMiD)
白血球介素
溶瘤病毒治療

第 6 章：全球免疫療法藥物市場，依給藥途徑分類，2019 - 2031 年（十億美元）

概述
靜脈注射 (IV)
口服
肌肉注射
皮下
其他

第 7 章：全球免疫療法藥物市場，依適應症分類，2019 - 2031 年（十億美元）

概述
癌症
肺癌
淋巴瘤
乳癌
皮膚癌
膀胱癌
大腸直腸癌
腎癌
其他
自體免疫疾病
其他

第 8 章：全球免疫療法藥物市場，依配銷通路，2019 - 2031 年（十億美元）

概述
醫院藥房
零售藥局
網路藥局

第 9 章：2019 - 2031 年全球免疫療法藥物市場（依地區）（十億美元）

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
英國
德國
義大利
法國
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
東協
澳洲
韓國
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
北非
中非
南非

第 10 章：競爭格局

公司簡介
- Bristol-Myers Squibb Company
- Pfizer Inc
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca
- Amgen Inc.
- GSK plc.
- Gilead Sciences, Inc.
- Johnson & Johnson
- Actym Therapeutics, Inc.
- Fate Therapeutics
- Gritstone bio
- Incyte
- Acumen Pharmaceuticals, Inc
- Arcus Biosciences, Inc.
- immunitybio inc
- Autolus Therapeutics
- ADC Therapeutics SA.
- BioNTech SE
- Cellectis

第 11 章：分析師建議

命運之輪
分析師觀點
連貫的機會圖

第 12 章：參考文獻與研究方法

參考
研究方法論

簡介目錄

Product Code: CMI525

Global immunotherapy drugs market is estimated to be valued at USD 166.55 Bn in 2024 and is expected to reach USD 351.73 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.3% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 166.55 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	11.30%	2031 Value Projection:	US$ 351.73 Bn

Figure . Global immunotherapy drugs market Share (%), By Region, 2024

Immunotherapy drugs utilize the body's immune system to fight cancer and other diseases. These drugs stimulate the immune system by either boosting existing immune cells or introducing new immune cells into the body. The major types of immunotherapies include monoclonal antibodies, cancer vaccines, checkpoint inhibitors, and adoptive cell transfer therapies. Immunotherapy drugs are increasingly becoming the standard of care for various cancer types as these have been shown to provide long-lasting response rates with milder side effects compared to chemotherapy. The market has witnessed significant growth over the past few years driven by new drug approvals and increasing adoption across different disease indications.

Market Dynamics:

Global immunotherapy drugs market growth is driven by rising prevalence of cancer and other chronic diseases worldwide. The market has gained momentum due to factors such as an increase in R&D funding for developing novel immunotherapies, consistent FDA approvals of immunotherapies, and superiority over other available treatment options. However, high costs associated with these drugs along with reimbursement issues in some regions act as key restraints for this market. The market players are also investing in pipeline products for expanding the current treatment landscape to new indications.

Key Features of the Study:

This report provides in-depth analysis of the global immunotherapy drugs market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global immunotherapy drugs market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Bristol-Myers Squibb Company, Pfizer Inc, Novartis AG, Merck & Co., Inc., AstraZeneca, Amgen Inc., GSK plc., Gilead Sciences, Inc., Johnson & Johnson, Actym Therapeutics, Inc., Fate Therapeutics., Gritstone bio, Incyte, Acumen Pharmaceuticals, Inc, Arcus Biosciences, Inc., immunitybio inc, Autolus Therapeutics, ADC Therapeutics SA., BioNTech SE, and Cellectis.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global immunotherapy drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunotherapy drugs market.

Detailed Segmentation-

Therapy Type:
- Immune checkpoint inhibitors
- Monoclonal antibodies
- Naked monoclonal antibodies
- Conjugated monoclonal antibodies
- Bispecific monoclonal antibodies
- Vaccines
- Preventive Vaccines
- Therapeutic Vaccines
- Adoptive Cell Therapies
- Tumor-infiltrating lymphocyte (TIL) therapy
- CAR T-cell therapy
- Engineered T-cell receptor (TCR) therapy
- Natural killer (NK) cell therapy
- Immune System Modulators
- Interferons
- Immunomodulators (IMiDs)
- Interleukins
- Oncolytic Virus Therapy
Route of Administration:
- Intravenous (IV)
- Oral
- Intramuscular
- Subcutaneous
- Others
Indication:
- Cancer
- Lung Cancer
- Lymphoma
- Breast Cancer
- Skin Cancer
- Bladder Cancer
- Colorectal Cancer
- Kidney Cancer
- Others
- Autoimmune Diseases
- Others
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Bristol-Myers Squibb Company
- Pfizer Inc
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca
- Amgen Inc.
- GSK plc.
- Gilead Sciences, Inc.
- Johnson & Johnson
- Actym Therapeutics, Inc.
- Fate Therapeutics.
- Gritstone bio
- Incyte
- Acumen Pharmaceuticals, Inc
- Arcus Biosciences, Inc.
- immunitybio inc
- Autolus Therapeutics
- ADC Therapeutics SA.
- BioNTech SE
- Cellectis

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Immunotherapy Drugs Market- Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Immunotherapy Drugs Market, By Therapy Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Immune checkpoint inhibitors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Monoclonal antibodies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Naked monoclonal antibodies
Conjugated monoclonal antibodies
Bispecific monoclonal antibodies
Vaccines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Preventive Vaccines
Therapeutic Vaccines
Adoptive Cell Therapies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Tumor-infiltrating lymphocyte (TIL) therapy
CAR T-cell therapy
Engineered T-cell receptor (TCR) therapy
Natural killer (NK) cell therapy
Immune System Modulators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Interferons
Immunomodulators (IMiDs)
Interleukins
Oncolytic Virus Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Immunotherapy Drugs Market, By Route of Administration, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Intravenous (IV)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Intramuscular
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Subcutaneous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Immunotherapy Drugs Market, By Indication, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Lung Cancer
Lymphoma
Breast Cancer
Skin Cancer
Bladder Cancer
Colorectal Cancer
Kidney Cancer
Others
Autoimmune Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Immunotherapy Drugs Market, By Distribution Channel, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

9. Global Immunotherapy Drugs Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Company Profiles
- Bristol-Myers Squibb Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Pfizer Inc
- Novartis AG
- Merck & Co., Inc.
- AstraZeneca
- Amgen Inc.
- GSK plc.
- Gilead Sciences, Inc.
- Johnson & Johnson
- Actym Therapeutics, Inc.
- Fate Therapeutics
- Gritstone bio
- Incyte
- Acumen Pharmaceuticals, Inc
- Arcus Biosciences, Inc.
- immunitybio inc
- Autolus Therapeutics
- ADC Therapeutics SA.
- BioNTech SE
- Cellectis